Xponance’s Cidara Therapeutics CDTX Stock Holding History

Xponance’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,532	Closed	-$338K	–	1700
2025 Q4	$338K	Buy	+1,532	New	+$248K	﹤0.01%	1117

Xponance's CDTX Position: Q1 2026 in Review

Xponance sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,532 shares — an estimated $338K sold.

Xponance first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $338K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Xponance reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Xponance sold 1,532 Cidara Therapeutics shares in Q1 2026, an estimated $338K.
Xponance first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Xponance's Cidara Therapeutics position peaked at $338K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.